Arecor Therapeutics PLC
Uttlesford, England, United Kingdom · Biopharma, Biotechnology, Health Care
Arecor Therapeutics PLC is a globally focused biopharmaceutical company transforming patient care by bringing innovative medicines to market through the enhancement of existing therapeutic products. By applying our innovative proprietary formulation technology platform, Arestat™, we are developing an internal portfolio of proprietary products in diabetes and other indications, as well as working w
Key facts
- Headquarters
- Uttlesford, England, United Kingdom
- Employees
- 37
- Industries
- Biopharma, Biotechnology, Health Care
- Status
- Private
- Website
- arecor.com
- Company page
Recent activity at Arecor Therapeutics PLC
Leadership
- David Ellam, Chief Financial Officer
- Maggie Mcconnell, Executive Assistant
- Hannah Ruczaj, Head of Human Resources
- Jan Jezek, Chief Scientific Officer
- Manjit Rahelu, Chief Business Officer
- Steven Lane, Director of Finance
Verified email and direct lines for Arecor Therapeutics PLC’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.
Arecor Therapeutics PLC in the news
- REG - Arecor Therapeutics - Retail Offer to raise up to £130,000 - TradingView (Sep 30, 2026)
- Arecor Therapeutics adds patents as it eyes $3 billion US market - Yahoo Finance UK (Oct 15, 2026)
- Arecor focus starting to pay big dividends - Business Weekly (Apr 12, 2026)
- Blackbird, Tertiary Minerals, Futura Medical, Arecor Therapeutics, Rainbow Rare Earths - Yahoo Finance (Oct 08, 2026)
- Arecor seeks £5.1m as insulin pump partnership talks reach term sheet stage - Yahoo Finance UK (Sep 30, 2026)
- Arecor's ultra-concentrated insulin holds ultra-rapid profile in peer-reviewed study - UPDATE - Yahoo! Finance Canada (Aug 12, 2026)
- Skye Bioscience Establishes Partnership with Arecor Therapeutics to Develop Enhanced Formulation of Obesity Candidate Nimacimab - Yahoo Finance (May 19, 2025)
- Anglo Asian Mining, Quantum Helium, Quadrise, Arecor Therapeutics - Small Cap Snapshot - Yahoo Finance (Oct 15, 2026)
Companies similar to Arecor Therapeutics PLC
- Windward Bio · Biopharma, Biotechnology, Health Care, Pharmaceutical, Therapeutics
- CASI Pharmaceuticals · Biopharma, Biotechnology, Health Care, Pharmaceutical, Therapeutics
- Cumulus Oncology · Biopharma, Biotechnology, Health Care, Pharmaceutical, Therapeutics
- BerGenBio ASA · Biopharma, Biotechnology, Health Care, Pharmaceutical, Therapeutics
- Apollomics · Biopharma, Biotechnology, Health Care, Pharmaceutical, Therapeutics
About Arecor Therapeutics PLC: questions and answers
What does Arecor Therapeutics PLC do?
Arecor Therapeutics PLC is a globally focused biopharmaceutical company transforming patient care by bringing innovative medicines to market through the enhancement of existing therapeutic products. By applying our innovative proprietary formulation technology platform, Arestat™, we are developing an internal portfolio of proprietary products in diabetes and other indications, as well as working w
Where is Arecor Therapeutics PLC headquartered?
Arecor Therapeutics PLC is headquartered in Uttlesford, England, United Kingdom.
How many employees does Arecor Therapeutics PLC have?
Arecor Therapeutics PLC has about 37 employees.
What is the latest news on Arecor Therapeutics PLC?
On Sep 25, 2025, Arecor Therapeutics Signs Co-development Agreement with Sequel Med Tech for AT278 and Secures Up to $11 Million in Funding.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy